Press & News

NEWS RELEASES

Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals

November 13, 2018 – PRNewswire

Enable Injections’ First Closing of Series B Round to Include a New Investor: Financing to Accelerate Commercial Manufacturing

Oct. 25, 2018 – PRNewswire

Enable Injections Granted U.S. Utility Patent in Expanding IP Portfolio

Mar. 23, 2018 – AccessWire

Enable Injections Names Jeannie Joughin, Ph.D. Executive Vice President and Chief Commercial Officer

Jan. 10, 2018 – Open PR

Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products

Jan, 8, 2018 – GlobeNewswire

Enable Injections Introduces First Multi-Vial/Multi-Syringe Biologics Delivery System For Several Pharma Partners at BIO 2017

Jun, 19, 2017 – PR Newswire

2017 Innovation & Technology Award winner: Enable Injections

Apr, 28, 2017 – Cincinnati Business Courier

CincyTech 2016: Here We Grow

Nov,15,2016 – cincytech

Enable Injections Closes $30M Series A Financing Led by ORI Healthcare

Oct, 05, 2016 – Business Wire

Enable Injections Completes Cincinnati Manufacturing Facility for On-Body Delivery Systems

Jun, 14, 2016 – Drug Development & Delivery

CincyTech predicts 600 new jobs with $30M fund

Apr, 18, 2016 – Cincinnati.com

Enable Injections and Flex Partner for Production of Wearable High Volume Injectors

Feb, 03, 2016 – BusinessWire